• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

薯蓣皂苷元通过上调 PTEN 抑制卵巢癌细胞增殖和迁移并诱导细胞凋亡。

Diosgenin inhibits proliferation and migration of ovarian cancer cells and induce apoptosis via upregulation of PTEN.

机构信息

Department of Gynecology, 3201 Hospital, HanZhong, China.

Department of Obstetrics, Laoling People's Hospital, Dezhou, China.

出版信息

Chem Biol Drug Des. 2024 Mar;103(3):e14459. doi: 10.1111/cbdd.14459.

DOI:10.1111/cbdd.14459
PMID:38538058
Abstract

Diosgenin, a natural steroidal sapogenin, has recently attracted a high amount of attention, as an effective anticancer agent in ovarian cancer. However, diosgenin mediated anticancer impacts are still not completely understood. Thus, the present study evaluated the effect of diosgenin on the proliferation, apoptosis, and metastasis of ovarian cancer cells. OVCAR-3 and SKOV-3 cells were treated with diosgenin, cellular viability was assessed by MTT assay and apoptosis was measured by ELISA and evaluated the protein expression levels of apoptotic markers through western blotting. Cell migration was examined by measuring the mRNA levels of genes involved in the cell invasion. The protein expression levels of main components of PI3K signaling were evaluated via western blotting. Diosgenin led to significant inhibition of cellular proliferation in a dose-dependent manner. It also induced apoptosis through upregulating pro-apoptotic markers and downregulating antiapoptotic mediators. In addition, OVCAR-3 cells exposure to diosgenin decreased cell migration and invasion. More importantly, diosgenin downregulated the expression levels of main proteins in PI3K signaling including PI3K, Akt, mTOR, and GSK3. Diosgenin inhibited the proliferation and migration of OVCAR-3 ovarian cancer cells and induced apoptosis, which may be mediated by targeting PI3K signaling.

摘要

薯蓣皂苷元,一种天然甾体皂素,最近受到了广泛关注,作为卵巢癌的一种有效抗癌药物。然而,薯蓣皂苷元介导的抗癌作用仍不完全清楚。因此,本研究评估了薯蓣皂苷元对卵巢癌细胞增殖、凋亡和转移的影响。用薯蓣皂苷元处理 OVCAR-3 和 SKOV-3 细胞,通过 MTT 法评估细胞活力,通过 ELISA 测量细胞凋亡,并通过 Western blot 评估凋亡标志物的蛋白表达水平。通过测量参与细胞侵袭的基因的 mRNA 水平来检测细胞迁移。通过 Western blot 评估 PI3K 信号主要成分的蛋白表达水平。薯蓣皂苷元以剂量依赖性方式显著抑制细胞增殖。它还通过上调促凋亡标志物和下调抗凋亡介质来诱导细胞凋亡。此外,薯蓣皂苷元处理 OVCAR-3 细胞可降低细胞迁移和侵袭。更重要的是,薯蓣皂苷元下调了 PI3K 信号中的主要蛋白表达水平,包括 PI3K、Akt、mTOR 和 GSK3。薯蓣皂苷元抑制 OVCAR-3 卵巢癌细胞的增殖和迁移,并诱导凋亡,这可能是通过靶向 PI3K 信号介导的。

相似文献

1
Diosgenin inhibits proliferation and migration of ovarian cancer cells and induce apoptosis via upregulation of PTEN.薯蓣皂苷元通过上调 PTEN 抑制卵巢癌细胞增殖和迁移并诱导细胞凋亡。
Chem Biol Drug Des. 2024 Mar;103(3):e14459. doi: 10.1111/cbdd.14459.
2
Betulin terpenoid targets OVCAR-3 human ovarian carcinoma cells by inducing mitochondrial mediated apoptosis, G2/M phase cell cycle arrest, inhibition of cell migration and invasion and modulating mTOR/PI3K/AKT signalling pathway.白桦脂萜类通过诱导线粒体介导的细胞凋亡、G2/M 期细胞周期阻滞、抑制细胞迁移和侵袭以及调节 mTOR/PI3K/AKT 信号通路来靶向人卵巢癌细胞 OVCAR-3。
Cell Mol Biol (Noisy-le-grand). 2021 Sep 29;67(2):14-19. doi: 10.14715/cmb/2021.67.2.3.
3
Kaempferol inhibits proliferation, migration, and invasion of liver cancer HepG2 cells by down-regulation of microRNA-21.山奈酚通过下调 microRNA-21 抑制肝癌 HepG2 细胞的增殖、迁移和侵袭。
Int J Immunopathol Pharmacol. 2018 Mar-Dec;32:2058738418814341. doi: 10.1177/2058738418814341.
4
Anhuienoside C inhibits human ovarian cancer cell growth by inducing apoptosis, suppression of cell migration and invasion, and targeting PI3K/AKT/mTOR signaling pathway.安怀苷 C 通过诱导细胞凋亡、抑制细胞迁移和侵袭以及靶向 PI3K/AKT/mTOR 信号通路来抑制人卵巢癌细胞生长。
Mol Cell Biochem. 2022 Jul;477(7):1887-1892. doi: 10.1007/s11010-022-04406-3. Epub 2022 Mar 29.
5
Anticancer effects of α-mangostin in OVACAR-3 human ovarian carcinoma cells are mediated via involvement of reactive oxygen species, mitochondrial -mediated apoptosis, suppression of cell migration and invasion and m-TOR/PI3K/AKT signaling pathway.α-倒捻子素通过活性氧、线粒体介导的细胞凋亡、抑制细胞迁移和侵袭以及 m-TOR/PI3K/AKT 信号通路的参与,对 OVACAR-3 人卵巢癌细胞发挥抗癌作用。
J BUON. 2020 Sep-Oct;25(5):2293-2300.
6
Activation of PI3K/Akt pathway by PTEN reduction and PIK3CA mRNA amplification contributes to cisplatin resistance in an ovarian cancer cell line.PTEN表达降低和PIK3CA mRNA扩增所致的PI3K/Akt信号通路激活促使卵巢癌细胞系产生顺铂耐药。
Gynecol Oncol. 2005 Apr;97(1):26-34. doi: 10.1016/j.ygyno.2004.11.051.
7
Girinimbine Inhibits the Proliferation of Human Ovarian Cancer Cells In Vitro via the Phosphatidylinositol-3-Kinase (PI3K)/Akt and the Mammalian Target of Rapamycin (mTOR) and Wnt/β-Catenin Signaling Pathways.吉尼希宾通过磷脂酰肌醇-3-激酶(PI3K)/Akt 和雷帕霉素靶蛋白(mTOR)及 Wnt/β-连环蛋白信号通路抑制人卵巢癌细胞的体外增殖。
Med Sci Monit. 2018 Aug 7;24:5480-5487. doi: 10.12659/MSM.910137.
8
Naturally occurring davanone terpenoid exhibits anticancer potential against ovarian cancer cells by inducing programmed cell death, by inducing caspase-dependent apoptosis, loss of mitochondrial membrane potential, inhibition of cell migration and invasion and targeting PI3K/AKT/MAPK signaling pathway.天然存在的大根香叶烯萜类化合物通过诱导细胞程序性死亡、诱导 caspase 依赖性细胞凋亡、线粒体膜电位丧失、抑制细胞迁移和侵袭以及靶向 PI3K/AKT/MAPK 信号通路,表现出对卵巢癌细胞的抗癌潜力。
J BUON. 2020 Sep-Oct;25(5):2301-2307.
9
Long noncoding RNA-JPX predicts the poor prognosis of ovarian cancer patients and promotes tumor cell proliferation, invasion and migration by the PI3K/Akt/mTOR signaling pathway.长链非编码 RNA-JPX 可预测卵巢癌患者的不良预后,并通过 PI3K/Akt/mTOR 信号通路促进肿瘤细胞增殖、侵袭和迁移。
Eur Rev Med Pharmacol Sci. 2018 Dec;22(23):8135-8144. doi: 10.26355/eurrev_201812_16505.
10
Effects of MicroRNA-19b on the Proliferation, Apoptosis, and Migration of Wilms' Tumor Cells Via the PTEN/PI3K/AKT Signaling Pathway.微小RNA-19b通过PTEN/PI3K/AKT信号通路对肾母细胞瘤细胞增殖、凋亡及迁移的影响
J Cell Biochem. 2017 Oct;118(10):3424-3434. doi: 10.1002/jcb.25999. Epub 2017 May 30.

引用本文的文献

1
Anti- Cancer Potential of Diosgenin, a Steroidal Saponin, against Human Oral Cancer Cells.甾体皂苷元薯蓣皂苷元对人口腔癌细胞的抗癌潜力
Asian Pac J Cancer Prev. 2025 Jun 1;26(6):2049-2059. doi: 10.31557/APJCP.2025.26.6.2049.
2
An Updated Review of Molecular Mechanisms Implicated with the Anticancer Potential of Diosgenin and Its Nanoformulations.薯蓣皂苷元及其纳米制剂抗癌潜力相关分子机制的最新综述
Drug Des Devel Ther. 2025 Mar 24;19:2205-2227. doi: 10.2147/DDDT.S502322. eCollection 2025.